SN
Sahil Nayyar
About Sahil Nayyar
Data last updated:
Sahil Nayyar is a Director at Gems Drugs Private Limited (since 2006) and Designated Partner at Compleo Solutions Llp (since 2017). The companies operate in Chemicals and Business Services. The largest current company by reported revenue is Gems Drugs Private Limited at ₹21.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Oct 2006 | 1990 | ₹21.9 Lakh (FY 2025) | Active | |
| Designated Partner | 16 May 2017 | 2017 | Active |
Board colleagues of Sahil Nayyar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajeev Nayyar | 01398509 | Gems Drugs Private Limited | Director |
| Ritu Nayyar | 01758124 | Gems Drugs Private Limited | Director |
| Jatin Gupta | 06766813 | Compleo Solutions Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sahil Nayyar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sahil Nayyar
Sahil Nayyar currently holds 2 directorships: Gems Drugs Private Limited (Director, since 06 Oct 2006, revenue ₹21.9 Lakh (FY 2025)); Compleo Solutions Llp (Designated Partner, since 16 May 2017).
Sahil Nayyar was first appointed on 06 Oct 2006 as Director at Gems Drugs Private Limited. The most recent appointment on record is 16 May 2017 at Compleo Solutions Llp.
The current boards of Sahil Nayyar's companies include Rajeev Nayyar (Gems Drugs Private Limited), Ritu Nayyar (Gems Drugs Private Limited), Jatin Gupta (Compleo Solutions Llp).